PORTFOLIO
Portfolio
-
NOVELTY NOBILITY -
Neuracle Genetics -
DAAN Biotherapeutics -
LigaChem Biosciences -
Regen Innopharm -
MasterMeditech -
MirimGENE -
BIORCHESTRA -
ViGenCell -
VaxCell Biotherapeutics -
CELLAPEUTICS BIO -
CELLEMEDY -
Cellid -
CdmoGen -
ARUM THERAPEUTICS -
IDIENCE -
iN Therapeutics -
ANTEROGEN -
SCM Lifescience -
SL Therapeutics -
FNCTBIOTECH -
Ensol Biosciences -
ELGEN THERAPEUTICS -
MTHERA PHARMA -
Y-Biologics -
Ubix Therapeutics -
IntoCell -
Illimis Therapeutics -
JD Bioscience -
Gencellmed -
GI Cell -
GI Innovation -
G2GBIO -
Kanaph Therapeutics -
CasCure Therapeutics -
ClavisTherapeutics -
Therapex -
Txinno Bioscience -
Pantilogos -
HysensBio -
Celloram -
GenEdit
DAYLI PARTNERS
201, Teheran-ro, Gangnam-gu, Seoul, Republic of Korea
Tel : +82-2-563-0890
Fax : +82-2-563-8787
E-mail : contact@dayli.partners
Copyright © 2024 DAYLI PARTNERS. ALL RIGHTS RESERVED